Zoe Kopp, Nathan Johnson and Chris Evans joined thought leaders in presenting data from a study to develop a new measure for overactive bladder trials at ICS Tokyo (13-16 September 2016).
Zoe Kopp, Nathan Johnson and Chris Evans joined thought leaders in presenting data from a study to develop a new measure for overactive bladder trials at ICS Tokyo (13-16 September 2016).